Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP) [Phase 3]
Long-term phase 3 trial in pediatric patients with immune thrombocytopenia assessing romiplostim safety and efficacy; study completed with r…
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP) [Phase 3]
A Phase 3 clinical trial update for BT595 in chronic primary immune thrombocytopenia (ITP) has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Safety and Efficacy of Eltrombopag at Escalated Doses [Phase 2]
Phase 2 trial assessing safety and efficacy of escalated doses of eltrombopag in immune thrombocytopenia, with completed status and results …
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP) [Phase 2]
Phase 2 trial evaluating eltrombopag targeting the Bcl-xL pathway in idiopathic thrombocytopenic purpura (immune thrombocytopenia) completed…
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura [Phase 3]
Phase 3 trial evaluating long-term dosing safety and efficacy of romiplostim in pediatric patients with immune thrombocytopenia purpura (ITP…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of R935788 for persistent or chronic immune thrombocytopenia has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2018-09-07Clinical Trial Update: H. Pylori Eradication for Moderate ITP [Phase 3]
Phase 3 trial investigating Helicobacter pylori eradication for immune thrombocytopenic purpura (ITP).
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia [Phase 2]
Phase 2 clinical trial evaluating low-dose decitabine for immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP [Phase 3]
Phase 3 trial comparing decitabine plus dexamethasone versus dexamethasone alone for management of immune thrombocytopenia, status not repor…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs) [Phase 2]
A Phase 2 trial evaluating eltrombopag for immune thrombocytopenia occurring in patients with chronic lymphoproliferative disorders has comp…
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia [Phase 4]
A Phase 4 trial update reporting completion of a study evaluating repositioning a second-line therapy for chronic immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 1, Phase 2]
This document discusses a Phase 1/Phase 2 clinical trial evaluating a three-drug combination (atorvastatin, acetylcysteine, and danazol) for…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Rituximab Combining Bortezomib Versus Rituximab in Management of ITP [Phase 3]
A Phase 3 trial evaluating rituximab combined with bortezomib versus rituximab alone for immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura) [Phase 3]
A Phase 3 randomized trial comparing oral E5501 to eltrombopag in adults with chronic immune thrombocytopenia (Idiopathic Thrombocytopenic P…
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02) [Phase 3]
Phase 3 trial update on the efficacy and safety of oral E5501 plus standard of care for adults with chronic immune thrombocytopenia; study c…
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 2]
This is a Phase 2 trial evaluating daily AKR-501 tablets for 28 days in patients with chronic immune thrombocytopenia; the study has complet…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects [Phase 1]
A Phase 1 study assessing the drug-drug interaction between eltrombopag and cyclosporine in healthy subjects has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP) [NA]
A completed clinical trial from Assistance Publique – Hôpitaux de Paris investigating polymorphism and auto-reactive B and T cell subsets in…
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: The Study of Different Dose Rituximab in the Treatment of ITP [Phase 4]
This clinical trial update reports a phase 4 study evaluating different doses of rituximab to treat immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia [Phase 3]
Phase 3 trial evaluating the efficacy and safety of dapsone as a second-line option in adults with immune thrombocytopenia; current status i…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia [Phase 3]
Phase 3 trial comparing daily prednisone to pulsed dexamethasone in treatment-naïve adults with immune thrombocytopenia has completed. Resul…
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia [Phase 3]
Phase 3 trial evaluating NewGam (intravenous immunoglobulin 10%) for primary immune thrombocytopenia; efficacy and safety results have been …
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: IGIV Study for Chronic ITP Patients Ages 3-70 [Phase 3]
A Phase 3 trial evaluating intravenous immunoglobulin for chronic immune thrombocytopenia in patients aged 3-70 has completed, with results …
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura [Phase 3]
A Phase 3 trial comparing prednisone versus dexamethasone as initial therapy for newly diagnosed, untreated immune thrombocytopenia has comp…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013
A retrospective chart review of 33 pediatric patients with immune thrombocytopenia treated with romiplostim or eltrombopag between 2009 and …